Detection rate is not higher for women with BBD history in breast cancer screening

Author:

Qu Penghuan1,Liu Xueou12,Huang Yubei1,Feng Ziwei1,Wang Xin1,Dai Hongji1,Zhang Liwen1,Song Fangfang1,Li Haixin13,Zheng Hong1,Song Fengju1,Chen Kexin1

Affiliation:

1. Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P. R. China

2. GCP Center Office, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin 300041, P. R. China

3. Department of Cancer Biobank, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P. R. China

Abstract

ABSTRACT Background To investigate whether women with benign breast disease (BBD) history have higher breast cancer detection rate in screening. Methods We reviewed data for 33 001 female participants in Multi-modality Independent Screening Trial (MIST). Corresponding data for 6823 breast cancer patients were retrieved from the Tianjin Breast Cancer Cases Cohort (TBCCC) and analyzed for comparison. Results The breast cancer detection rate was 2.83‰ among women with BBD history and 3.28‰ in women without. Moreover, the proportion of carcinoma in situ (CIS) was also lower in women with BBD history than women without (7.69 versus 20.31%). In contrast, analysis of TBCCC data revealed a higher proportion of CIS in patients with BBD history (5.05%) than patients without (3.26%). Our data showed that a larger proportion of women with BBD history had undergone previous breast examinations. Additionally, among participants diagnosed with both breast cancer and BBD in MIST, we found a lower proportion of CIS in women with BBD history (11.76%) compared to women without (32.14%). Conclusions Women with BBD history were not found to have higher detection rate in breast cancer screening. Women with BBD history were more likely to be proactive in seeking breast examinations and to have breast cancer be diagnosed in clinic.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

The Net Construction of Human Genetic Resource Bio-bank in North China

National Human Genetic Resources Sharing Service Platform

Program for Changjiang Scholars and Innovative Research Team in University in China

Tianjin Municipal Key Health Research Program

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,General Medicine

Reference28 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. A blueprint for cancer screening and early detection: advancing screening's contribution to cancer control;Wender;CA Cancer J Clin,2018

3. Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese breast cancer registry;Iwamoto;Breast Cancer Res Treat,2016

4. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France);Vanier;Cancer Epidemiol,2013

5. Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study;Lau;Hong Kong Med J,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3